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AbstrACt
Introduction Poor medicines management places patients 
at risk, particularly during care transitions. For patients with 
heart failure (HF), optimal medicines management is crucial 
to control symptoms and prevent hospital readmission. 
This study explored the concept of resilience using HF 
as an example condition to understand how the system 
compensates for known and unknown weaknesses.
Methods We explored resilience using a mixed-methods 
approach in four healthcare economies in the north of 
England. Data from hospital site observations, healthcare 
staff and patient interviews, and documentary analysis 
were collected between June 2016 and March 2017. Data 
were synthesised and analysed using framework analysis.
results Interviews were conducted with 45 healthcare 
professionals, with 20 patients at three time points 
and 189 hours of observation were undertaken. We 
identified four primary inter-related themes concerning 
organisational resilience. These were named as gaps, 
traps, bridges and props. Gaps were discontinuities 
in processes that had the potential to result in poorly 
optimised medicines. Traps were features of the system 
that could produce errors or unintended adverse 
medication events. Bridges were features of the medicines 
management system that promoted safety and continuity 
which ensured that, despite varying conditions, care could 
be delivered successfully. Props were informal, temporary 
or impromptu actions taken by patients or healthcare staff 
to avoid potential adverse events.
Conclusion The numerous opportunities for HF patient 
safety to be compromised and for suboptimal medicines 
management during this common care transition are 
mitigated by system resilience. Cross-organisational 
bridges and temporary fixes or ‘props’ put in place by 
patients and carers, healthcare teams and organisations 
are critical for safe and optimal care to be delivered in the 
face of continued system pressures.
IntroduCtIon
The WHO views the safe management of 
medicines as a global challenge.1 In the 
UK, guidance stresses the importance of 
improving the way medicines are managed 
at care transitions, such as admission to and 
discharge from hospital.2 However, there is 
continued evidence that systems managing 
medicines are not optimally calibrated, partic-
ularly during and after hospital discharge,3 
when the responsibility for patient care shifts 
across organisations and clinicians.4 
Medicines management is a system that 
supports the therapeutic use of medicines 
by patients, involving multiple healthcare 
organisations and staff with different clin-
ical specialties and professional roles.5 There 
is no shortage of evidence about the points 
at which healthcare systems fail to provide 
safe care.6–9 Patients are not always well 
prepared to leave hospital and self-manage 
strengths and limitations of this study
 ► Using four geographical areas and mixed methods, 
this study explored medicines management for peo-
ple with heart failure at a time of considerable risk.
 ► Multiple viewpoints of patients and staff highlighted 
how the system is resilient in the face of pressure 
and weaknesses.
 ► The study presents a framework within which to 
explore and understand resilience in healthcare 
systems: that of ‘bridges’ and ‘props’ set against a 
backdrop of ‘gaps’ and ‘traps’.
 ► The study collected multiple viewpoints but did not 
include the perspectives of local, regional and na-
tional policymakers.
 ► The patients and staff who agreed to be interviewed 
may have had particularly positive or negative expe-
riences of the system, although their accounts were 
augmented and triangulated by first-hand indepen-
dent observations.
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their ongoing treatment.10 The effective transfer of 
sufficient and accurate information between healthcare 
organisations remains inadequate in many cases4 and is 
compounded by boundaries between care providers who 
may not always have access to the same information about 
patients’ health. It is then unsurprising that discrepan-
cies arise between medicines lists held by different care 
providers and patients.3 11 12
Heart failure (HF) is a chronic condition affecting 
900 000 individuals in the UK and is projected to rise 
significantly with an ageing population.13 HF is a costly 
condition for the National Health Service (NHS) and is 
characterised by high rates of readmissions.14 HF symp-
toms and disease progression can be controlled through 
well-managed medicines; however, guidelines for their 
use are not always applied and cardiology medicines can 
also cause harm, such as kidney injury, if they are not 
monitored.15 Hence, the optimal management of medi-
cines when leaving hospital is crucial to enhance quality 
of life, manage symptoms, prevent deterioration leading 
to hospital readmission and reduce mortality.16
Current thinking in patient safety has shifted focus from 
the deconstruction of events leading up to safety incidents 
(Safety I) to a more positive and proactive view of health-
care systems that identifies and values what goes right as 
well as pinpointing what goes wrong (Safety II).17 18 Thus 
Safety II focuses on preventing error while accepting that 
there is variability in the delivery of healthcare, acknowl-
edging that patients do not always experience harm as 
a consequence of their care. Instead of reacting when 
things go wrong, organisations proactively anticipate 
developments, negative as well as positive. It offers recog-
nition of good performance in the face of uncertainty, 
valuing flexibility, adaptability, foresight and knowledge 
of how systems operate.17 19 This in turn promotes a 
more dynamic attitude to performance through resil-
ience which is the ability for a system and the individuals 
therein to adjust prior to, during or following changes 
or disturbances or in the face of ongoing, sustained pres-
sure.18 20–22
This concept of resilience in healthcare has looked at 
specific points in the patient pathway such as handover 
of care between staff in one location such as a ward or 
performing specific roles.19 23 24 Only one previous study 
has explored how patients can enhance resilience in 
medicines management at and after hospital discharge 
through anticipating discrepancies and taking remedial 
action.25 No studies to date have explored resilience 
in medicines management at this care transition from 
multiple perspectives, including staff and patients and 
across different healthcare economies.
This study aimed to address this evidence gap by system-
atically investigating resilience in the medicines manage-
ment system, using HF as an example condition. More 
specifically, the study was designed to understand how the 
system compensates for weaknesses and maximises oppor-
tunities in order to deliver safe yet optimal treatment. 
Its objectives were to explore the system of medicines 
management in multiple healthcare economies to high-
light where resilience exists and identify where improve-
ments to the system can be made to enhance resilience.
Methods
We used a mixed-methods design in four healthcare 
economies and their local primary care organisations 
(one comprising two hospitals and three comprising one 
hospital) in the north of England. Sites were selected 
to include university teaching hospitals and non-univer-
sity teaching hospitals in different areas. Data from site 
observations, staff and patient qualitative interviews and 
documentary analysis (discharge letters and organisa-
tional and national policies) were collected between June 
2016 and March 2017. NHS research ethics committee 
approval was sought and granted (16/NS/0018).
Patient involvement
A patient researcher was a member of the research team 
advising on patient recruitment, data collection materials 
and information and consent forms. The research was 
overseen by a patient-led steering group including people 
with HF and carers.
data collection
Observations
Following ward-level consent, three experienced health 
researchers (BF, HI, IM) conducted a total of 189 hours of 
observations in five cardiology wards and one HF clinic. 
Structured observation schedules developed by the 
research team informed by previous work26 were used to 
record observations. We observed medicines and ward 
rounds, preparation of information for discharge, patient 
discharges, as well as any other impromptu medicines-re-
lated activities. Unstructured, contemporaneous field 
notes were taken by the researchers.
Patient recruitment
A quota sample of four to six patients in each site was 
constructed, aiming for at least 16 complete data sets in 
total in the four areas. Patients were recruited during 
hospital admission by research nurses in consultation 
with ward staff. Patients were eligible for the study if they 
were aged 18 years or older, had capacity to consent and 
had been admitted to hospital with a diagnosis of HF with 
reduced ejection fraction (<45%) measured by an echo-
cardiogram within the last 5 years. Patients also needed to 
present New York Heart Association Class III symptoms.27 
Research nurses approached eligible patients to intro-
duce the study. Patients were then provided with a partici-
pant information leaflet and given the opportunity to ask 
questions about the study; they were given at least 4 hours 
to decide whether or not to take part.
Patient interviews
Patients’ experiences with their medicines were explored 
at three time points: at, or as soon as practicable, after 
discharge (covering experience from admission to 
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discharge) and then approximately 2 and 6 weeks later. 
The research team developed a semistructured interview 
schedule built on previous work26 and a review of relevant 
literature. The schedule comprised questions relating to 
patients’ experiences with their medicines, and prompts 
and probes were used when relevant. Two researchers 
conducted the interviews (BF, HI). Interviews lasted up to 
60 min, took place in patients’ homes and were video or 
audio recorded and transcribed verbatim.
Healthcare staff recruitment
Healthcare professionals with a role in medicines manage-
ment in primary or secondary care were approached to 
take part in a semistructured interview either by research 
nurses or the study team, using face-to-face communica-
tion or by email invitation. A range of healthcare profes-
sionals involved in medicines management were selected 
following ward observations.
Healthcare staff interviews
An interview schedule was developed by the research team 
to explore staff perceptions of safe medicines manage-
ment. The schedule focused on medicines management 
processes, staff views on its quality and effectiveness for 
patients with HF in primary and secondary care, and 
their experiences of medicines management at discharge 
from secondary to primary care. Staff were given a partic-
ipant information leaflet describing the study and, if 
they agreed to take part, an appointment was made to 
conduct the interview. Interviews lasted up to 60 min, 
were audio recorded following written consent and tran-
scribed verbatim.
Analysis of key documents
Documents were identified and reviewed including: 
national guidance on medicines optimisation used in 
the hospital setting2; local policies on medicines manage-
ment and discharge in the four health economies; case 
notes and communications such as discharge letters, and 
any patient information about medicines in use in the 
four hospitals and available as text. Examples of potential 
system resilience at care transitions and risks in the system 
were identified and using a framework that mapped them 
according to the point in the transition to which they 
related and to the resilience element (or lack of) they 
evidenced.19
data analysis
The process of data analysis was iterative and comparative: 
analysing the first round of interview and observation data 
as further interviews and observations were undertaken; 
providing the opportunity to explore emerging themes in 
greater detail in subsequent fieldwork. The research team 
met several times both during and following data collec-
tion to discuss the data synthesis and analysis method and 
the emerging themes. Interview data were synthesised 
through data extraction with the data from observations 
and documents and the combined data were analysed 
using the framework approach,28 involving detailed 
familiarisation with the data, identifying themes, inter-
preting the findings within the context of similar research 
studies and considering policy and practice.
results
A total of 55 interviews with 20 patients with HF were 
conducted: 19 at discharge or shortly afterwards 
(time point 1); 19 approximately 2 weeks after discharge 
(time point 2); and 17 approximately 6 weeks after 
discharge (time point 3). We were unable to contact 
one patient from site 1 at time point 1; at site 2 one 
patient withdrew from the study after the first interview. 
One patient from site 3 was not interviewed at the third 
time point due to hospital readmission, and at site 4 one 
patient was too ill to continue after the second interview. 
Table 1 presents the number of patients interviewed for 
each site at the different time points. Table 2 outlines the 
gender and age of interviewed patients.
Forty-five interviews (table 3) were conducted with 
healthcare professionals: 19 with primary care staff (15 
in four general practitioner (GP) surgeries, two commu-
nity pharmacists and two community HF nurses) and 26 
with secondary care staff. Table 4 presents the number of 
healthcare staff interviewed by site.
We identified four primary inter-related themes 
concerning organisational resilience and termed these: 
gaps, traps, bridges and props. Examples representing 
each theme are shown in tables 5–8.
‘Gaps’ were defined as a discontinuity in key processes 
that form the medicines management system and had 
the potential to result in poorly optimised medicines. 
Table 1 The number of patients interviewed at each 
time point by site
Site Time point 1 Time point 2 Time point 3
Site 1 2 3 3
Site 2 5 4 4
Site 3 6 6 5
Site 4 6 6 5
Total 19 19 17
Table 2 The gender and age of patients who took part in 
interviews
Site Gender Total Age range
Site 1 Male 2 72–82
Female 1 53
Site 2 Male 5 40–89
Female 0 0
Site 3 Male 5 46–79
Female 1 69
Site 4 Male 4 46–78
Female 2 69–76
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Approaches to preparing discharge information varied 
across sites, with information sometimes being missed due 
to a lack of preparation time. Gaps were also evident in the 
information shared with primary care and in the prepa-
ration of patients to use their medicines. For the latter, 
we identified no standardised processes for informing 
patients about their medicines and, while hospital poli-
cies stipulated that patients should be informed, and gave 
details of the types of information patients should have, 
there was no guidance on optimal methods for informing 
patients about their medicines or training, so patients’ 
experiences of receiving medicines were inconsistent and 
information was deficient for some.
Discussions with some nurses during observations re-
vealed that while they were aware of policies in place 
on what aspects to cover when discussing medicines 
with patients at discharge, they did not follow them 
and often rushed these conversations. (Site 2, field 
notes from ward observations)
After discharge we found gaps in the continuity of 
care, for example, not all patients had a community 
pharmacy Medicines Use Review because pharmacies 
did not routinely receive information about the patients’ 
medicines at discharge. Waiting times for specialist 
staff follow-up varied considerably and were sometimes 
lengthy, for example, waiting times for an appointment 
with community HF specialist nurses who would manage 
medicines titration was sometimes as long as 3 months 
after discharge.
We defined ‘traps’ as features of the way the medicines 
management system was designed or managed that might 
produce medication errors defined as a ‘failure in the 
treatment process that leads to, or has the potential to 
lead to, harm to the patient’29 30 or unintended adverse 
medication events. These were evident in the coordina-
tion of discharges, for example, the pressure on ward staff 
to expedite discharges as quickly as possible appeared to 
impact on the effective preparation of discharge infor-
mation and on educating patients about their discharge 
medicines.
If you’re busy, you’ll write less and I think that’s just 
what happens on the job. If I know I’ve got time, I’ll 
make sure I input as much detail as possible, but if 
you’re busy you just don’t have the time to do that, so 
you’ll just really do short summaries and just include 
the bare essentials. (Site 1, FY1 doctor)
Staff preparing discharge information were often inter-
rupted, could not always locate patients’ notes and none 
reported receiving training about safe practices with 
medicines at discharge to primary care. We also found 
error traps after discharge, such as a lack of time and 
resources in GP surgeries to process discharge informa-
tion. Finally, there was evidence that patients’ lack of 
knowledge about the purpose of their medicines could 
potentially cause confusion particularly when the changes 
made in hospital led patients to have different supplies 
or multiple multicompartment ‘compliance aid’ tablet 
boxes. Like hospital staff, none of the primary care staff 
had received formal training about safe practices with 
medicines at discharge to primary care.
‘Bridges’ were identified as formalised features of the 
medicines management system that had been made 
permanent and promoted the safety and continuity of 
medicines management. They ensured that, despite 
varying conditions, care could be delivered successfully 
to patients with HF.
When preparing the ‘To Take Home’ medicines at 
discharge, ward staff wait for the pharmacist to come 
to the ward to check the patients' medicines lists and 
ensure these are accurate and any errors can be recti-
fied. (Site 2, field notes from ward observations)
Table 3 Number of interviews by healthcare staff type
Staff type
Number 
of 
interviews
GPs 4
Practice administrators/data quality managers 2
Practice pharmacists 3
Practice nurses 1
Practice managers 3
Community pharmacists 2
Community heart failure nurses 2
Clinical care coordinators 1
Community cardiac nurses 1
Cardiologists 3
Ward managers 5
Staff nurses 2
Junior sisters 1
Ward pharmacists 3
Specialist cardiology pharmacists 2
Consultant pharmacists 1
Junior doctors 2
Specialist heart failure nurses 3
Ward administrative staff 4
Total 45
GP, general practitioner.
Table 4 The number of healthcare staff interviewed per site
Site Primary/community care Secondary care
Site 1 6 7
Site 2 4 8
Site 3 2 4
Site 4 7 7
Total 19 26
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Bridges also included methods of communicating with 
primary care about treatment, for example, when hospi-
tals sent an electronic copy of the patient’s discharge 
summary to their GP. In this case, summaries were put 
together by multidisciplinary teams including junior 
doctors, nurses and pharmacists who would check and 
add information about medicines that would be useful 
to the primary care team. After discharge, two partici-
pating hospital trusts ran pharmacist-led titration clinics 
to ensure that medicine doses were optimised. Titration 
clinics also meant patients would be seen more quickly 
than if they had to see a consultant cardiologist. One 
cardiology pharmacist explained that the titration clinic 
ensured patients’ medicines were adjusted as and when 
appropriate, in light of some GPs not feeling confident 
about changing them.
GP practices differed in how they processed discharge 
information. In one practice, administrative staff would 
review the discharge summary and forward actions to 
practice staff if medicines information needed to be 
changed. In another practice, this task was the respon-
sibility of the GP, who would forward actions to practice 
staff and book any tests needed as a consequence of any 
changes in medicines occurring during hospital stay 
(ie, blood tests). One GP reported that his practice had 
re-engineered their processing of discharge summaries 
to include a multidisciplinary team comprising adminis-
trative staff, a practice-based pharmacist (whose post was 
created in response to recognised safety risks) and GPs, 
with the pharmacist taking responsibility for coordinating 
the process.
And so [processing discharge summaries] it was 
in-between surgeries, it was at the end of the day, so it 
was being fitted in rather than having allocated time, 
so naturally when it’s being fitted in the process is a 
bit more rushed, you’re more under pressure, may-
be your concentration levels aren't there, so mistakes 
can be easily made. So as a practice we made the de-
cision that just in terms of a workload thing and also 
patient safety and efficiency it would be worth invest-
ing in sort of pharmacy services. (GP, site 1)
Practice pharmacists perceived that their specialist 
knowledge improved as a consequence of being 
involved in the discharge process, while further expe-
diting the safe management of medicines for patients 
after discharge. Some practice staff described having 
targets in place linked to time taken to process 
discharge summaries, with some practices prioritising 
processing driven by the risk of readmission. One data 
quality manager explained that they tried to process 
discharges within 24 hours of receiving information 
from the hospital, including reconciling medicines, but 
also explained that they had a maximum of a week to 
complete it.
Table 5 Gaps at and after hospital discharge
At discharge After discharge
Gaps Discussions about medicines at discharge can be rushed 
due to time pressures and workload.
Community pharmacy is not integrated into 
communication about discharge medicines.
No standard process or guidance on how to hold 
discussions with patients about medicines.
Patients are not routinely referred to community 
pharmacy for follow-up support.
Limited or no formal training about care transitions, preparing 
discharge summaries or patients to use medicines for all 
staff.
Limitations to the extent of shared IT systems between 
primary and secondary care and between surgeries and 
pharmacies.
Processes for preparing patients to go home with medicines 
are linear but not streamlined, for example, multiple staff 
members need to input which causes delays.
Not all surgeries have a practice pharmacist to reconcile 
medicines.
Discharge summary information is technical and uses 
jargon and abbreviations which are difficult for patients to 
understand.
Long waiting times to access community heart failure 
nurse services (up to 12 weeks).
Inconsistency in level of detail in information written on 
discharge summary due to workload and healthcare staff 
knowledge of the patient.
Some patients perceive limitations in posthospital 
follow-up care, including difficulty in accessing services 
in primary care.
Varying information offered to patients about follow-up 
appointments.
Patients are not fully aware of the roles and skills of 
primary care staff, particularly community pharmacists.
Limited awareness among staff about policies in place for 
medicines management.
Some patients unable to devise effective strategies to 
self-manage medicines at home.
Effectiveness of discharge is not critically appraised due to 
lack of feedback (unless the patient is readmitted or primary 
care staff make queries).
IT, information technology.
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So we have a week turnaround in order to get any 
meds reconciliation done. We generally get our elec-
tronic discharge normally within 24 hours of the 
patient being discharged, that would be scanned 
through the system that will then go to the doctor, the 
doctor will then forward it to me generally for cod-
ing and also to our practice pharmacist. (Data quality 
manager, site 2)
‘Props’ were informal, temporary or impromptu actions 
taken by patients or healthcare staff to avoid potential 
adverse events, such as medication errors. Props were 
sometimes developed in response to risks in the working 
environment, such as interruptions during medicines 
rounds.
During medicines rounds, nurses are frequently in-
terrupted whilst sorting patients' medicines. One 
nurse observed also uses the strategy of signing the 
drug chart soon as one medicine is sorted into the 
plastic cup before moving to the next medicine. If 
there are interruptions, the nurse will know which 
medicines have already been sorted by looking at the 
drug chart. The nurse says it is a brilliant strategy to 
ensure accuracy and safety and cope with inevitable 
distractions and interruptions. (Site 1, field notes 
from ward observations)
Hospital staff told us that they suspected recommen-
dations made by the hospital (eg, the uptitration of 
doses which is critical in HF) may not be acted on in 
primary care. Hence, staff created solutions to prevent 
a break in the ongoing treatment, giving patients an 
extra copy of their discharge letter to take to the GP. 
Some staff members described being cognisant of how 
discharge information can be difficult for patients to 
understand and would take extra time to explain the 
discharge summary and any abbreviations contained 
within it. One staff nurse at site 1 described having to 
make protected time to hold these discussions with 
patients, drawing curtains around the patients’ beds to 
prevent any disruption. Some patients reported being 
discharged with an insufficient amount of medicines, 
leading them to seek community pharmacists help to 
provide them with emergency supplies until they could 
see a GP. Some patients also proactively provided the 
necessary links between community pharmacy, GPs and 
Table 6 Traps at and after hospital discharge
At discharge After discharge
Traps Patient knowledge of medicines when they are 
discharged is limited.
Community pharmacy does not routinely receive copies of 
patients' discharge summaries so cannot correct or query 
new GP prescriptions.
There is pressure on ward staff to discharge patients 
and free-up beds.
Patients have an ongoing lack of knowledge of their 
medicines once home.
Variation in ward staffing levels and varying numbers of 
discharges to perform each day.
No formal training for surgery staff to process discharge 
information.
Use of several different IT systems in producing 
information for discharge.
Lack of time and resources in surgery to process discharge 
information.
Staff preparing patients for discharge and information 
about discharge medicines are interrupted.
Systems allow old prescriptions to be issued when medicines 
have changed.
Preparing information for discharge routinely left to 
junior members of staff who may not be familiar with 
the patient.
Dosages are monitored and changed by staff in different 
organisations.
Conversations about medicines with patients at 
discharge can be left to the last minute.
Trust in healthcare professionals may lead to a lack of 
patient critical appraisal of the condition and medicines.
Patients transferred to discharge lounges to await 
medicines face an extra transfer of care.
Changes in medicines lead to patients having conflicting 
medicines and multicompartment compliance aid boxes at 
home.
Varying levels of communication across care organisations 
results in extra burden to patient who has to fill in the gaps.
Varying information about medicines changes provided to 
primary care may lead to healthcare staff having to make 
decisions based on assumptions.
Healthcare professions may not accept treatment 
recommendation by other healthcare professionals (eg, GP 
not accepting recommendations made by Heart Failure 
Specialist Nurse).
GP, general practitioner; IT, information technology.
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the hospital after discharge. For example, one patient 
called the community pharmacy to ask what informa-
tion, if any, they had been provided with about his 
medicines. Another patient provided their GP practice 
with information about dose changes.
So when I’d run out, I rang my GP and they were 
blissfully unaware of any changes to the amount, the 
receptionist had to take it down. She says ‘well what 
was you on?’ and I said ‘well I was on one tablet a 
day and then they took me down to half, then they 
put me to one tablet a day again and now I’m on two 
tablets a day.’ ‘Two tablets?’, this is the receptionist’s 
questions. I says ‘yeah, two tablets.’ (Patient 05, site 4, 
interview 2)
Finally, community pharmacists stepped in to organise 
supplies for patients when something had gone wrong 
and the patient was unable to get the correct medicines.
dIsCussIon
Notwithstanding a considerable body of research that has illu-
minated the sometimes alarming levels of preventable harm 
in healthcare systems and how this could be reduced,31 32 
this study suggests that there are opportunities to enhance 
the system that manages medicines across multiple organ-
isations. The study also provides a positive perspective 
on the strategies developed and actions taken by health-
care organisations, their staff and patients to provide care 
successfully in the face of continued pressure and gaps that 
appear between and between organisations in this complex 
system.33 The multiple perspectives of patients and multi-
disciplinary staff, independent observation of practice and 
documentary analysis collected through mixed methods 
allowed the possibility of triangulating data from multiple 
sources to offer a thorough description of a complex system. 
In doing so we also present a framework within which to 
explore and understand resilience in healthcare systems: 
that of ‘bridges’ and ‘props’ set against a backdrop of ‘gaps’ 
and ‘traps’. Moreover, this study explores a whole healthcare 
system inclusive of its transitions, to reveal the context of 
that system. In contrast, previous studies, although adding 
to an understanding of system resilience, have examined 
these problems from solely a health professional perspec-
tive23 or a patient perspective.25
Table 7 Bridges at and after discharge
At discharge After discharge
Bridges Hospitals have established methods of communicating 
about patients' treatment with primary care.
Some trusts provide outpatient clinics where patients can 
receive intravenous fluids, thus avoiding them to need to 
be admitted to receive these medicines or speeding up 
discharges.
Preparing discharge summaries and To Take Out (TTO) 
lists is a multidisciplinary task involving nurses and 
pharmacists.
GP practices have systems for acting on discharge 
information once it is received, although processes and 
times to process this information vary.
Ward pharmacists can expedite well-managed discharge 
through proactively creating TTO lists.
Some practices have targets in place linked to time 
to process discharge information (eg, 24 hours from 
receiving this information).
One trust routinely referred patients to community 
pharmacy for follow-up support with their medicines.
One practice pharmacist re-engineered the process for 
action on discharge information.
All hospitals had policies for informing patients about their 
medicines.
Some practices use practice pharmacists to improve and 
expedite the processing of discharge information.
Heart failure nursing staff attempted to see patients 
before their discharge to talk about their medicines to 
avoid having these conversations rushed at discharge.
Community pharmacy is sometimes able to perform 
postdischarge Medicines Use Review for patients.
In two trusts, ward-based pharmacists would speak to 
patients about their medicines before discharge.
Two hospital trusts run pharmacist-led titration clinics to 
manage patients' medicines, meaning that patients can 
be seen and followed up quickly.
Patients received written information about their 
medicines, with one trust providing an easy-to-
understand medicines chart occasionally annotated by 
staff.
Some practices have ambulatory services.
Patients are referred to specialist heart failure teams for 
follow-up.
Heart failure specialist nurses offer support services 
including medicines optimisation.
Some GP practices have systems to identify discharged 
patients with high risk of being readmitted so they can 
take preventative action.
GP, general practitioner.
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Bridges and props either provided permanent system 
adaptations to potential gaps in care, or temporary fixes, 
usually implemented by individuals or small teams. Some-
times the props were put in place despite organisational 
pressure, for example, to discharge patients and free 
beds. We also draw out the dissonance between what 
healthcare professionals believe should happen and the 
reality of contemporary practice. This was clear from the 
differences between the recommendations for hospital 
discharge from national guidance and local policy, where, 
for example, patients must be fully informed about their 
medicines and any changes, and the overall discharge 
process—which in the settings observed, may lack depth 
and the necessary detail, or appear rushed. This was 
sometimes due to different local conditions, such as 
the number of discharges that needed to be completed 
in a day, but also to local policies that lacked sufficient 
detail and were not supported by staff training. Health-
care systems are complex and non-linear and the Safety 
II paradigm asserts that success and failures are products 
of the same variable system performance and that linear 
models of events such as medication errors cannot reflect 
the complexity of modern healthcare systems.34 An 
enhanced view of the system using a Safety II lens allows 
healthcare organisations and policymakers to understand 
and close the gap between work as imagined versus work 
Table 8 Props at and after hospital discharge
At discharge After discharge
Props Some staff create their own checklists to follow discharge 
processes, such as using the discharge summary to tick off 
medicines.
Patients create their own lists of medicines, going 
online to seek more information.
Staff occasionally give patients two copies of the discharge 
summary so that patients can give one to their GPs in case 
they do not receive it electronically.
Community pharmacists who have received a copy 
of the discharge summary use them to check against 
repeat prescriptions before dispensing.
Staff make ad hoc queries to establish reasons for 
medicines changes which are unclear and undocumented 
so that they can be clear on the discharge summary.
Patients check medicines prescribed by their GPs 
against their discharge summary and/or take a copy 
when go see the GP or update them verbally.
Staff will delay discharge to wait for relatives to arrive 
so that they can include them in conversations about 
medicines.
GP identifying potentially problematic changes in 
medicines occurring in hospital due to their enhanced 
knowledge of the patient.
Ward pharmacists give advice to patients if they are 
concerned about patients getting confused, for example, 
advising them to return their old medicines to the pharmacy 
for disposal and only take the new ones.
GPs try to fill in patients' knowledge gaps about their 
medicines after discharge.
Patients write additional information on the medicines' 
boxes or ask staff to write it so that they can better 
manage their medicines at home, for example, time to take 
medicines.
Community pharmacy provides emergency supply of 
medicines when patients are discharged from hospital 
without sufficient medicines.
Patients are sometimes cognisant of how difficult it is for 
patients to understand their medicines and information 
provided at discharge, so they take extra time to hold these 
conversations.
Patients are given telephone numbers for heart failure 
nurses to contact them after discharge because 
waiting times to be seen by them are long.
Staff draw curtains around the patients' beds when talking 
to them to ensure privacy and prevent interruptions.
Heart failure nurses can identify where patients 
make mistakes taking their medicines, for example, 
continuing to take discontinued medicines.
Nurses resist instructions to send patients to discharge 
lounges as they feel the staff will not have specialist 
knowledge, and provide enhanced instructions to discharge 
lounge if over-ruled.
Heart failure nurses use the patients as a conduit for 
information to be exchanged between them and other 
healthcare professionals.
Junior doctors query with pharmacist on ward if they need 
additional information about medicines.
Patients develop individual strategies and routines to 
adhere to medicines at home, for example, alarms, 
writing additional information in the discharge 
summary, storage systems, affixing discharge 
summaries on the fridge, and so on.
Some patients take all their medicines to community 
pharmacy after discharge, seeking information on 
which medicines they should continue to take and 
which should be discarded.
GP, general practitioner.
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as done.35 This view also provides a better understanding 
of how policies and guidelines are actually interpreted 
and whether they are implemented in healthcare organ-
isations by staff who adjust their performance to deliver 
care in a complex system.
Resilient systems are able to learn from their clinical 
experience (both positive and negative), adapt to it 
and respond to provide successful outcomes.36 37 It was 
evident that staff were able to anticipate system vulnera-
bilities, for example, in the transfer of discharge informa-
tion, and take compensatory adaptive action in the form 
of ‘props’. As found by a previous study, patients also took 
remedial action, such as providing missing information 
about medicines changes to staff.25 Resilient systems can 
monitor, learn and anticipate opportunities to improve. 
A better understanding and acceptance of the error traps 
in the system present healthcare organisations with the 
opportunity to learn about how the system operates, 
particularly when it is under pressure and presents a 
basis to improve. A better knowledge of gaps allows staff 
to anticipate where problems may occur and take action 
to avoid them. Props in the system are indicators of how 
flexible staff and teams are and healthcare systems can 
learn from the temporary fixes put in place and knowing 
where bridges have successfully joined up care can help 
systems learn and be better placed to innovate elsewhere. 
There are opportunities to learn from the ‘ordinary 
performance adjustments’ that staff undertake to better 
understand how to keep patients safe,37 thereby formal-
ising system props into bridges.
Implications for policy and practice
Successive UK government-commissioned reports have 
highlighted how care systems have failed and how the 
actions—or inactions of those who lead or contribute 
to the system—have sometimes led to poor care and 
patient harm.38–40 Policymakers should recognise the 
attempts made routinely by healthcare professionals and 
teams to learn from their clinical experience and apply 
this learning to increase system resilience by delivering 
safer care for patients despite disruptive conditions, 
such as disconnected communication systems, varying 
staffing levels and the underprovision of formal training, 
for example, in discharge and care transfers. Our study 
has shown that improvements to both the efficiency and 
safety of care could be gained through connecting the 
discrete information technology systems that operate 
within and between organisations. Additionally, commu-
nity pharmacists often remain isolated from the patient 
pathway and are not routinely included in the communi-
cation between secondary care and primary care practice, 
creating additional risk for patients with HF who must 
obtain new supplies of critical medicines often within 1 
or 2 weeks of being discharged.4 Implementing systems 
that enable community pharmacists to know about medi-
cines changes made during hospital admissions and thus 
to reconcile subsequent GP prescriptions would improve 
safety of medicines management, especially for patients 
with HF whose medicines are very commonly changed 
following a period of acute care. Local electronic systems 
do exist in a small number of areas to ensure that the 
dispensers of postdischarge medicines are fully informed 
about the medicines hospital clinicians intended patients 
should take so that they can reconcile those medicines 
and ensure accurate ongoing supplies.41 Policymakers 
also have a duty to help disseminate and promote 
implementation of these local innovations—such as the 
transfer of discharge medicines information to all agents 
in the medicines management system—which minimise 
inherent risk.
Patients, if they so desire, should also be provided with 
the opportunity to gain in-depth knowledge of their 
medicines before leaving hospital (or afterwards if they 
prefer), in order to enhance their ability to self-manage 
and monitor their condition; such knowledge might also 
increase patients’ vigilance, their capacity for error detec-
tion, and therefore to ask for prompt support if medica-
tion problems arise. Materials to support patients should 
be developed using codesign methods to maximise their 
acceptability and usability with both patients and health-
care staff.42 Policymakers may also consider allowing 
patients to write to and share a personal health record to 
keep track of and flag problems they may have with their 
medicines, and share these with their healthcare teams 
and report them to their care providers.43 This would in 
some measure help address the under-reporting of medi-
cation errors, particularly in primary care.44
We found that staff received little formal training 
in coordinating medicines management, including in 
completing discharge summaries, and there was little 
evidence of interprofessional or cross-pathway training. 
Such training may foster a care environment where clin-
ical and administrative staff have a better appreciation 
of the impact of the care they provide on different parts 
of the system, and on different colleagues. For example, 
how inadequate information on a discharge summary 
can cause difficulties for primary care staff attempting 
to reconcile medicines. Additionally, in primary care, 
understanding that the processing of discharge informa-
tion can impact on patients and community pharmacists 
who must take action to ensure the correct medicines are 
supplied. Interprofessional education has been found to 
yield positive outcomes in healthcare and may be espe-
cially helpful here, although more evidence for its effec-
tiveness has been called for.45
Implications for future research
The Safety I paradigm produced valuable ways of 
unearthing and visualising risks within systems and 
explaining causation when accidents occur.32 In health-
care systems, Safety II can add substantially by focusing 
on how safe care is delivered in the face of disruption and 
pressure by way of bridges, props or both, from individual, 
micro (eg, healthcare teams) and macro (eg, organi-
sational) perspectives.19 Investigating further how this 
happens for different health conditions using tailored 
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methodologies will allow a better understanding of safe, 
resilient care, and afford commissioners a view of how 
changes to services may impact on a complex system.46
limitations
We observed practice in four NHS trusts and interviewed 
a wide range of healthcare staff across the pathway and 
patients, alongside reviewing key documents, we did not 
include the perspectives of local, regional and national 
policymakers, which may have enhanced the under-
standing of how systems are designed and the gaps between 
design and delivery. Nevertheless, we were able to collect 
a large amount of data to compare policy practice which 
enhanced reliability and validity. The patients and staff 
who agreed to be interviewed may have had particularly 
positive or negative experiences of the system, although 
their accounts were triangulated by first-hand indepen-
dent observations. Finally, the study was conducted in 
four NHS healthcare economies, at a time of heightened 
focus on the quality of healthcare, and reports of unprec-
edented financial constraints, which may have impacted 
on people’s perspectives of care received and delivered, 
and on the nature of the care observed.
ConClusIon
There are numerous opportunities for patient safety 
to be compromised and medicines to be suboptimally 
managed during this care transition. However, there are 
also cross-organisational bridges and temporary fixes in 
the form of props, put in place by individuals, including 
patients and carers, and teams to maximise the oppor-
tunity for safe and optimal care to be delivered. Inves-
tigating gaps and traps in the healthcare system and 
identifying existing compensatory props and bridges 
allow the illustration of areas where healthcare can be 
improved and fragmented communication minimised 
during care transitions.
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